Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Eating healthy plant-based diet linked to reduced risk of colorectal cancer

Eating a plant-based diet rich in healthy plant foods - such as whole grains, vegetables, and legumes - and low in unhealthy plant foods - including refined grains, fruit juices, and added sugars - is associated with a lower risk of colorectal cancer in men.

29 Nov 2022

How Can CPNs Revolutionize Medical Diagnostics?

At MEDICA 2022, NewsMedical spoke with Andy Chaloner about Stream Bio's conjugated polymer nanoparticle technologies that have the potential to revolutionize the medical and life sciences sectors, from diagnostics to clinical imaging.

From Stream Bio 25 Nov 2022

Over 440 SCI articles published! BGI’s cancer genetics and cell research fuels innovation

BGI has currently published over 440 SCI (Science Citation Index) papers in the field of cancer research, with a cumulative impact factor of over 4,000 points.

From BGI Genomics 23 Nov 2022

Microniches of intratumoral microbiota impact spatial and cellular heterogeneity in cancer

Researchers mapped spatial, cellular, and molecular interactions of host and tumor-associated bacteria within the tumor microenvironment.

22 Nov 2022

CAR T-cell therapy in colorectal cancer

Researchers assessed the efficacy of CAR T-cells in the immunotherapy of colorectal cancer.

21 Nov 2022

The role of bacteria in cancer growth

Tumor-associated microbiota is an important component of the tumor microenvironment (TME) across 33 types of human cancer. However, little evidence is available regarding the spatial distribution and localization of these microbes in tumor cells.

20 Nov 2022

Dietary change could be a key to enhancing colon cancer treatment

A dietary change could be a key to enhancing colon cancer treatment, a new study from the University of Michigan Rogel Cancer Center finds.

20 Nov 2022

Study finds a positive impact of exercise on the gut microbiome of cancer patients

Regular physical activity can extend colorectal cancer patients' lives. In a first-ever study, scientists looked at the impact of exercise on the gut microbiome of cancer patients and reported a positive association.

14 Nov 2022

Researchers discover residual tumor cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum.

9 Nov 2022

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

In a new study, researchers assessed the risk of colorectal cancer (CRC) with the intake of flavonoids.

31 Oct 2022

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet of fresh fruits and vegetables may reduce the prevalence of cancers, including GC (Eusebi et al., 2020; Liu et al., 2021).

28 Oct 2022

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. From 2014 to 2018, overall cancer incidence, or new cases of cancer, remained stable for men and children but increased for women and adolescents and young adults.

28 Oct 2022

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

27 Oct 2022

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

As part of an interdisciplinary project of the LOEWE Centre Frankfurt Cancer Institute (FCI), researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, and Goethe University Frankfurt have succeeded in identifying a new approach for the therapy of colorectal cancer.

27 Oct 2022

Henry Ford Hospital earns three-year accreditation from National Accreditation Program for Rectal Cancer

Henry Ford Hospital has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), which was developed through a collaboration between the OSTRiCh (Optimizing the Surgical Treatment of Rectal Cancer) consortium and the Commission on Cancer, a quality program of the American College of Surgeons.

20 Oct 2022

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Virginia Tech researchers from the Department of Biomedical Engineering and Mechanics and the Department of Biochemistry have discovered a characteristic of a common oral bacterium that relocates to pancreatic cancer tumors that may help guide future therapeutic interventions for treatment.

18 Oct 2022

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®) - are equally effective for screening patients with early-stage colorectal cancer.

17 Oct 2022

Study finds highlight the potential for lowering rehabilitation utilization for colorectal patients

The first months of the COVID pandemic had a profound effect on hospital discharge practices and use patterns for patients with colorectal disease, according to findings presented at the Scientific Forum of the American College of Surgeons Clinical Congress 2022.

17 Oct 2022

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Eating healthy plant-based diet linked to reduced risk of colorectal cancer

How Can CPNs Revolutionize Medical Diagnostics?

Over 440 SCI articles published! BGI’s cancer genetics and cell research fuels innovation

Microniches of intratumoral microbiota impact spatial and cellular heterogeneity in cancer

CAR T-cell therapy in colorectal cancer

The role of bacteria in cancer growth

Dietary change could be a key to enhancing colon cancer treatment

Study finds a positive impact of exercise on the gut microbiome of cancer patients

Researchers discover residual tumor cells responsible for colon cancer relapse

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

Commensal gut microbes from IBD patients produce genotoxic metabolites

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

Henry Ford Hospital earns three-year accreditation from National Accreditation Program for Rectal Cancer

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

Study finds highlight the potential for lowering rehabilitation utilization for colorectal patients

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in